Korro Bio Inc expected to post a loss of $2.36 a share - Earnings Preview

Korro Bio

06/03/2024 13:54

* Korro Bio Inc  KRRO.OQ   KRRO.O  is expected to show no
change
in quarterly revenue when it reports  results on March 8
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Korro Bio Inc is for a
loss of
$2.36 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Korro Bio
Inc is
$110.00​, above​ its last closing price of $49.94. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -16.50      -17.72     -15.50    Beat    12.6
 Jun. 30 2023  -17.34      -17.76     -15.00    Beat    15.6
 Mar. 31 2023  -20.50      -21.02     -27.50    Missed  -30.8​
 Dec. 31 2022  -28.50      -31.54     -24.50    Beat    22.3
 ​​Sep.        -27.97      -28.46     -27.50    Beat    3.4
 30 2022                                                
 Jun. 30 2022  -34.98      -33.65     -30.50    Beat    9.4​
 Mar. 31 2022  -31.06      -31.75     -33.50    Missed  -5.5
 Dec. 31 2021  29.37       7.62       -31.00    Missed  -506.8
 This summary was machine generated March 6 at 13:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)